PL3021838T3 - Leczenie otyłości - Google Patents

Leczenie otyłości

Info

Publication number
PL3021838T3
PL3021838T3 PL14825724T PL14825724T PL3021838T3 PL 3021838 T3 PL3021838 T3 PL 3021838T3 PL 14825724 T PL14825724 T PL 14825724T PL 14825724 T PL14825724 T PL 14825724T PL 3021838 T3 PL3021838 T3 PL 3021838T3
Authority
PL
Poland
Prior art keywords
obesity
treatment
Prior art date
Application number
PL14825724T
Other languages
English (en)
Inventor
Moise A. Khayrallah
Gary Bream
Stephen E. Butts
Original Assignee
Jazz Pharmaceuticals Ireland Limited
Sk Biopharmaceuticals Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jazz Pharmaceuticals Ireland Limited, Sk Biopharmaceuticals Co., Ltd filed Critical Jazz Pharmaceuticals Ireland Limited
Publication of PL3021838T3 publication Critical patent/PL3021838T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL14825724T 2013-07-18 2014-07-18 Leczenie otyłości PL3021838T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361847593P 2013-07-18 2013-07-18
PCT/US2014/047186 WO2015010014A1 (en) 2013-07-18 2014-07-18 Treatment for obesity
EP14825724.9A EP3021838B1 (en) 2013-07-18 2014-07-18 Treatment for obesity

Publications (1)

Publication Number Publication Date
PL3021838T3 true PL3021838T3 (pl) 2021-03-08

Family

ID=52344067

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14825724T PL3021838T3 (pl) 2013-07-18 2014-07-18 Leczenie otyłości

Country Status (12)

Country Link
US (6) US9226910B2 (pl)
EP (1) EP3021838B1 (pl)
JP (2) JP6529495B2 (pl)
KR (1) KR102309836B1 (pl)
CN (2) CN110638804A (pl)
CA (1) CA2917702A1 (pl)
DK (1) DK3021838T3 (pl)
ES (1) ES2812586T3 (pl)
PL (1) PL3021838T3 (pl)
PT (1) PT3021838T (pl)
TW (1) TW201919605A (pl)
WO (1) WO2015010014A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3021838T3 (pl) * 2013-07-18 2021-03-08 Jazz Pharmaceuticals Ireland Limited Leczenie otyłości
TWI655179B (zh) * 2014-02-28 2019-04-01 南韓商愛思開生物製藥股份有限公司 胺基羰基胺基甲酸酯化合物
US10661504B2 (en) * 2015-03-02 2020-05-26 Funfare, Llc Three dimensional printer and cartridge
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
CN120574152A (zh) 2016-09-06 2025-09-02 爱尔兰贾兹制药有限公司 (r)-2-氨基-3-苯丙基氨基甲酸酯盐酸盐的溶剂化物形式的晶体、其制备方法、组合物及用途
MY202185A (en) 2016-10-06 2024-04-15 Jazz Pharmaceuticals Ireland Ltd Carbamoyl phenylalaninol compounds and uses therof
EP3630072A4 (en) 2017-06-02 2021-03-10 Jazz Pharmaceuticals Ireland Limited METHODS AND COMPOSITIONS FOR TREATMENT OF EXCESSIVE Drowsiness
MX2020001146A (es) 2017-07-31 2020-08-20 Jazz Pharmaceuticals Ireland Ltd Analogos de carbamoil fenilalaninol y usos de los mismos.
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function
EP4033068A1 (en) 2021-01-25 2022-07-27 Welltec A/S Downhole wireline tool string
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
WO2025006965A1 (en) 2023-06-29 2025-01-02 Axsome Therapeutics, Inc. Methods of administering solriamfetol to lactating women
WO2025098416A1 (zh) * 2023-11-06 2025-05-15 甘李药业股份有限公司 用于减肥的glp-1化合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ314570A (en) 1993-06-10 2000-11-24 Lilly Co Eli Treatment of emesis using tetrahydrobenz[cd]indole-6-carboxamides
KR100197892B1 (ko) 1994-09-09 1999-06-15 남창우 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법
US5756817C1 (en) 1995-02-11 2001-04-17 Sk Corp O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same
KR0173862B1 (ko) 1995-02-11 1999-04-01 조규향 O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
KR0173863B1 (ko) 1995-04-10 1999-04-01 조규향 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
DE69618663T2 (de) 1996-10-10 2002-08-14 Sk Corp., Seoul/Soul O-carbamoyl-phenylalaninol-zusammensetzungen und ihre pharmazeutisch anwendbaren salzen
WO1998017636A1 (en) 1996-10-22 1998-04-30 Ortho Pharmaceutical Corporation Phenylalaninol derivatives for the treatment of central nervous system disorders
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
US20040029941A1 (en) * 2002-05-06 2004-02-12 Jennings Julianne E. Zonisamide use in obesity and eating disorders
TW200507850A (en) * 2003-07-25 2005-03-01 Kyowa Hakko Kogyo Kk Pharmaceutical composition
US20050080268A1 (en) 2003-10-08 2005-04-14 Yong-Moon Choi Process of preparing O-carbamoyl compounds in the presence of active amine group
KR20070083826A (ko) 2004-10-28 2007-08-24 에스케이 주식회사 우울증을 위한 부가 요법
AU2006254899B2 (en) * 2005-06-08 2011-11-24 Sk Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
DE602006012670D1 (de) 2005-06-22 2010-04-15 Sk Holdings Co Ltd Behandlung der sexuellen dysfunktion
CA2616721C (en) 2005-07-26 2014-01-21 Janssen Pharmaceutica N.V. Methods for treating substance-related disorders
CA2673487A1 (en) 2006-10-13 2008-04-24 Janssen Pharmaceutica Nv Phenylalkylamino carbamate compositions
CA2622696A1 (en) * 2007-11-05 2009-05-05 Diane Mcintosh Methods and compositions for retarding weight gain associated with use of atypical antipsychotic drugs
WO2009129181A1 (en) 2008-04-14 2009-10-22 Concert Pharmaceuticals Inc. Propanediol-dicarbamate derivatives
RU2567801C2 (ru) * 2009-06-22 2015-11-10 Ск Биофармасъютиклс Ко., Лтд. Способы лечения и профилактики усталости
US8232315B2 (en) * 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
KR101783632B1 (ko) 2009-11-06 2017-10-10 에스케이바이오팜 주식회사 주의력 결핍/과잉행동 장애(ａｄｈｄ)의 치료 방법
WO2011055944A2 (en) 2009-11-06 2011-05-12 Sk Holdings Co., Ltd. Methods for treating fibromyalgia syndrome
WO2011108724A1 (ja) * 2010-03-04 2011-09-09 味の素株式会社 糖尿病又は肥満症の予防又は治療剤
US9610274B2 (en) * 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9359290B2 (en) 2013-03-13 2016-06-07 Jazz Pharmaceuticals International Iii Limited Treatment of cataplexy
PL3021838T3 (pl) * 2013-07-18 2021-03-08 Jazz Pharmaceuticals Ireland Limited Leczenie otyłości

Also Published As

Publication number Publication date
KR102309836B1 (ko) 2021-10-12
US9226910B2 (en) 2016-01-05
JP2019089859A (ja) 2019-06-13
EP3021838A1 (en) 2016-05-25
US20150025136A1 (en) 2015-01-22
US20210077450A1 (en) 2021-03-18
US20160081970A1 (en) 2016-03-24
US9649291B2 (en) 2017-05-16
JP6824315B2 (ja) 2021-02-03
CN105873576B (zh) 2019-07-19
WO2015010014A1 (en) 2015-01-22
KR20160032127A (ko) 2016-03-23
PT3021838T (pt) 2020-09-01
JP6529495B2 (ja) 2019-06-12
EP3021838A4 (en) 2017-01-18
ES2812586T3 (es) 2021-03-17
US20170340596A1 (en) 2017-11-30
CN105873576A (zh) 2016-08-17
US10105341B2 (en) 2018-10-23
TW201919605A (zh) 2019-06-01
US20230172896A1 (en) 2023-06-08
DK3021838T3 (da) 2020-08-24
US11497725B2 (en) 2022-11-15
US20190099395A1 (en) 2019-04-04
CA2917702A1 (en) 2015-01-22
US12201601B2 (en) 2025-01-21
JP2016532679A (ja) 2016-10-20
EP3021838B1 (en) 2020-05-27
CN110638804A (zh) 2020-01-03

Similar Documents

Publication Publication Date Title
PT3021838T (pt) Tratamento para a obesidade
IL244869A0 (en) Device treatment
GB201300928D0 (en) Apparatus
GB2512025B (en) Surface treatment device
GB201302789D0 (en) Apparatus
GB201304872D0 (en) Treatment
GB201308440D0 (en) Therapeutic
GB201312419D0 (en) Manipulation treatment apparatus
GB201310755D0 (en) Therapy
IL245463A0 (en) valve
GB2509800B8 (en) Splint
GB201320855D0 (en) Apparatus
GB201318668D0 (en) Sonosensitive therapeutic
GB2511850B (en) Cooking Apparatus
GB201307310D0 (en) Treatment
GB201316521D0 (en) Therapeutic apparatus
GB201319954D0 (en) Apparatus
GB201311738D0 (en) Apparatus
GB201310529D0 (en) Traysealing apparatus
GB2509801B (en) Splint
GB201304811D0 (en) Novel treatment for hypertension
GB201300968D0 (en) Apparatus
GB201321115D0 (en) Treatment
GB201309238D0 (en) Treatment
PH22013000280U1 (en) Splint